Ascus Biosciences

Ascus Biosciences

Ascus Biosciences

Ascus Biosciences uses novel microbial community screening methods to discover, develop, and commercialize next generation feed additives.
Type
B2b
Founded
2015
Raised
$46M
Follow us
Alexa global traffic share
Latest funding
$46,000,000
Venture capital (Series B) - 2020
Formation 8 Temasek Holdings Anterra Capital +1
Team Size
1–10
Employees
$46,000,000 Venture capital (Series B)
DealStreetAsia , AgFunderNews

Temasek leads $46m funding in US animal nutrition firm Ascus Biosciences

FinSMEs

Ascus Biosciences Closes $46M in Series B Funding